Why is carperitide approved only in Japan?

Carperitide was developed and approved in Japan in 1995 based on Japanese clinical trials. Western regulatory bodies (FDA, EMA) have not approved it, partly because no sponsor pursued Western clinical trials and because similar agents like nesiritide (recombinant BNP) were developed for Western markets.

What is the difference between ANP and BNP?

ANP (28 AA) is released primarily from atrial cardiomyocytes in response to atrial stretch, while BNP (32 AA) is released mainly from ventricular cardiomyocytes in response to ventricular wall stress. Both signal through NPR-A and have similar effects (vasodilation, natriuresis), but BNP has a slightly longer half-life. BNP/NT-proBNP is more widely used as a clinical biomarker for heart failure.

Is ANP used as a biomarker?

Yes. The mid-regional fragment of pro-atrial natriuretic peptide (MR-proANP) is an established heart failure biomarker, validated in the BACH trial. It is particularly useful when BNP may be unreliable (e.g., patients on sacubitril-valsartan, which elevates BNP but not MR-proANP).

What is the recommended dose range for Atrial Natriuretic Peptide?

The research dose range is 0.025–0.05 mcg/kg/min (carperitide, Japan), administered via Intravenous infusion, Continuous.

peptide dosing

Atrial Natriuretic Peptide Dosing & Reconstitution Guide

Complete dosing reference for Atrial Natriuretic Peptide (Cardiovascular / Natriuretic). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Intravenous infusion Frequency: Continuous Dose Range: 0.025–0.05 mcg/kg/min (carperitide, Japan)

Safety & Contraindications

Safety: Hypotension is the primary adverse effect and is dose-dependent Japanese post-marketing surveillance reported increased in-hospital mortality in the higher-dose groups (ATTEND registry analysis, Mebazaa et al., Eur J Heart Fail 2015, PMID: 25684603) Bradycardia may occur due to vagal stimulation

Contraindications: Severe hypotension (systolic BP <90 mmHg); Cardiogenic shock; Severe aortic or mitral stenosis

Peptide Tools

Reconstitution CalculatorCalculate concentration and syringe units for any peptide vial with visual syringe guide.

Dosage & Cycle PlannerPlan a multi-week peptide cycle. Calculate total supply needed and vial counts.

Bacteriostatic Water CalculatorCalculate how many vials of bacteriostatic water you need for your peptide stack.

Cost-Per-Milligram CalculatorCompare vendors side-by-side. Find the best value per milligram and per dose.

Frequently Asked Questions

Related Resources

Browse All Research Peptides

Explore More

Atrial Natriuretic Peptide Dosing Guide Peptides for Acute Heart Failure (Japan)Peptides for Cardiac Biomarker

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.